Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 274 No 7346 p483
23 April 2005

This article
Reprint   Photocopy

  Acrobat Reader


News summary


LMW heparins similar

A trial comparing two low molecular weight heparins, tinzaparin and dalteparin, shows that both provide effective and safe outpatient treatment of deep vein thrombosis and pulmonary embolism (Archives of Internal Medicine 2005;165:733).

Back to Top


©The Pharmaceutical Journal